• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Veterinary/Animal Vaccines Market Size

    ID: MRFR/Pharma/1994-CR
    133 Pages
    Kinjoll Dey
    May 2019

    Veterinary (Animal) Vaccines Market Research Report Information By Type (Livestock Vaccines, Porcine Vaccines), Technology (Live Attenuated Vaccines, Inactivated Vaccines), and Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa) - Forecast till 2032

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Veterinary/Animal Vaccines Market Infographic
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Veterinary Animal Vaccines Size

    Veterinary/Animal Vaccines Market Growth Projections and Opportunities

    Several key factors are driving the hemiplegic migraine market. Medical knowledge and diagnostic skills have increased. More people are getting specialized treatment for this rare and serious type of migraine as doctors get better at identifying and treating them. Sector changes are also caused by a genetic part of hemiplegic headaches. Because people with a family history of headaches are more likely to go to the doctor, we need targeted medicines and drugs that target genetic factors. More people around the world are getting migraines, which is good for the hemiplegic migraine business. As headaches become more common, doctors are learning more about migraines that cause hemiplegia. Because of this, there is more focus on choosing the right treatment for each disease. Neurological research has advanced, influencing the creation of new hemiplegic migraine treatments. As we learn more about brain activities under the surface, pharmaceutical firms may develop and provide more effective medicines for this market. Progress in the industry is linked to patient education and empowerment measures. Once people understand the signs and effects of hemiplegic migraines, they may seek medical guidance and consider their treatment choices. This will increase demand for readily accessible specialist medical services and pharmaceuticals. Pharmaceutical firms' effort to developing novel migraine treatments, especially for hemiplegic migraines, has helped grow the migraine market. Novel medications with specific modes of action and fewer side effects provide patients more treatment alternatives. Thus, patients have more therapeutic options. Healthcare infrastructure development worldwide is crucial for treating hemiplegic migraines. The industry benefits from the availability of specialized healthcare facilities, neurologists, and diagnostic technology that help diagnose and treat neurological illnesses early. Because these criteria help detect neurological disorders early. Patient advocacy organizations and support networks affect the hemiplegic migraine market. These organizations promote community and encourage people to actively seek medical treatment by sharing information, resources, and experiences. They allow sufferers to share their experiences. Insurance coverage and reimbursement mechanisms for hemiplegic migraine therapies affect market dynamics. The industry is fueled by the fact that insurance money motivates people to undertake major medical procedures and treatments. Telemedicine and digital health platforms make hemiplegic migraine sufferers more accessible to medical consultations. Because they can get medical consultations more readily. This technology allows doctors to quickly diagnose and treat patients, benefiting the business. International collaborations are needed to better study hemiplegic migraines. Global cooperation in scientific research and clinical trials bring together many viewpoints and resources, speeding up the development of novel treatment methods and therapeutic choices. Public health activities that treat and educate about migraines may have caused market growth. Both government and non-government groups have helped raise awareness of migraines, particularly hemiplegic ones, by identifying symptoms and raising the need for specialist medical treatments.

    Veterinary/Animal Vaccines Market Size Graph

    Market Summary

    The Global Veterinary Vaccines Market is projected to grow from 6.27 USD Billion in 2024 to 15.4 USD Billion by 2032.

    Key Market Trends & Highlights

    Veterinary (Animal) Vaccines Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate of 8.48 percent from 2024 to 2032. By 2032, the market valuation is anticipated to reach 15.4 USD Billion, indicating robust growth potential. In 2024, the market is valued at 6.27 USD Billion, reflecting a strong foundation for future expansion. Growing adoption of advanced vaccination technologies due to increasing awareness of animal health is a major market driver.

    Market Size & Forecast

    2024 Market Size 6.27 (USD Billion)
    2032 Market Size 15.4 (USD Billion)
    CAGR (2024-2032) 8.48%
    Largest Regional Market Share in 2024 latin_america)

    Major Players

    <p>Zoetis, Virbac SA, Merck, Phibro Animal Health Corporation, Boehringer Ingelheim, Ceva, Elanco</p>

    Market Trends

    Drivers

    As the middle classes around the world explode, so does the preference to keep pets. Most people keep cats and dogs as pets.. These pets need vaccines in order to stay healthy. This is one large driver of growth in the veterinary/animal vaccines market. 

    Growing middle classes around the world means that the demand for meat consumption is rising dramatically around the world. This raises the importance of veterinary vaccines because farm animals need to be vaccinated before they are slaughtered for human consumption. 

    This keeps the meat healthier and helps it last longer. It also keeps animals from developing dangerous bacteria, parasites, and viruses that can harm or even kill humans. In fact, according to the international veterinary vaccines and diagnostics conference 2006 the demand for various types of animal vaccines will increase dramatically in later years. 

    Opportunities

    There are many emerging opportunities in the veterinary/animal vaccines market. Many veterinary clinics are investing heavily in research and development to develop and market more advanced vaccines that will keep animals healthier and stronger and help them live longer. 

    Vaccines for animals are also getting a strong boost from technological advancements. It’s advancements in technology that promise to make a new generation of stronger animal vaccines that are much more effective and last longer. 

    Research and development will also allow vaccine manufacturers to develop and market hybrid vaccines. These will be much more effective, hence they will be extremely profitable. 

    Restraints

    All vaccines have side effects. Animal vaccines are no exception. This is a key restraint in the veterinary/animal vaccines market. Most farmers and pet owners are loath to get their animals vaccinated because they are all too aware of the side effects but they are not aware enough of the benefits of these vaccines. Most farmers don’t get their animals vaccinated for this reason. This is the case in developing nations. 

    The animal vaccine market is also heavily regulated. This is another factor that’s holding back growth in the Veterinary (Animal) Vaccines Market. 

    Challenges

    Some animal vaccines for some segments of animals are very expensive. This factor is a major challenge in the veterinary/animal vaccines market. Animal vaccine manufacturers will also have to find ways to better educate animal owners about the benefits of animal vaccines. 

    Technology analysis

    Merck is a major American player in the Veterinary (Animal) Vaccines Market. It became an industry leader by creating a sustainable competitive advantage. Intensive investments in research and development have allowed it to do this. In the field of animal research, the value of vaccines has been established significantly. 

    Animals and pets have both been immunized for many years. In the near future, beekeepers might be able to immunize their colonies. As of October 2022, the first honeybee vaccine in the world is being developed by the University of Georgia College of Agricultural and Environmental Sciences (CAES) and Dalan Animal Health.

    <p>The ongoing advancements in veterinary vaccine development are poised to enhance animal health outcomes and may contribute to the overall sustainability of livestock production systems.</p>

    U.S. Department of Agriculture (USDA)

    Veterinary/Animal Vaccines Market Market Drivers

    Rising Pet Ownership

    The increasing trend of pet ownership globally is a primary driver for the Global Veterinary Animal Vaccines Market Industry. As more households adopt pets, the demand for veterinary services, including vaccinations, rises significantly. In 2024, the market is valued at 6.27 USD Billion, reflecting the growing concern among pet owners for their animals' health. This trend is particularly pronounced in urban areas, where pet ownership rates have surged. Consequently, the need for effective vaccines to prevent diseases in pets is becoming more critical, thereby propelling the market forward.

    Market Growth Projections

    The Global Veterinary Animal Vaccines Market Industry is projected to experience substantial growth in the coming years. With a market value of 6.27 USD Billion in 2024, it is anticipated to reach 15.4 USD Billion by 2035. This growth trajectory indicates a compound annual growth rate of 8.48% from 2025 to 2035. Such projections reflect the increasing demand for veterinary vaccines driven by factors such as rising pet ownership, advancements in vaccine technology, and heightened awareness of animal health. The market's expansion is indicative of the critical role that vaccines play in ensuring the health and well-being of animals globally.

    Emerging Zoonotic Diseases

    The emergence of zoonotic diseases is a significant driver for the Global Veterinary Animal Vaccines Market Industry. As new diseases that can be transmitted from animals to humans arise, there is an urgent need for effective vaccination strategies to control outbreaks. This concern is particularly relevant in regions where livestock and wildlife interactions are frequent. The increasing incidence of such diseases highlights the necessity for robust vaccination programs, thereby propelling market growth. The focus on preventing zoonotic diseases is expected to contribute to the overall expansion of the market in the coming years.

    Regulatory Support and Standards

    Regulatory frameworks and standards established by government agencies play a crucial role in shaping the Global Veterinary Animal Vaccines Market Industry. Governments worldwide are implementing stringent regulations to ensure the safety and efficacy of veterinary vaccines. This regulatory support fosters consumer confidence and encourages veterinarians to adopt new vaccines. Moreover, compliance with these regulations often leads to improved product quality, which can enhance market growth. As the industry evolves, adherence to these standards will likely remain a key driver for the market, ensuring that animal health is prioritized.

    Advancements in Vaccine Technology

    Technological advancements in vaccine development are transforming the Global Veterinary Animal Vaccines Market Industry. Innovations such as recombinant vaccines and mRNA technology are enhancing vaccine efficacy and safety. These advancements not only improve the immune response in animals but also reduce the incidence of adverse effects. As a result, veterinarians are more likely to recommend these modern vaccines, further driving market growth. The anticipated market expansion to 15.4 USD Billion by 2035 underscores the importance of these technological developments in meeting the evolving needs of animal health.

    Increased Awareness of Animal Health

    There is a growing awareness among pet owners and livestock producers regarding the importance of animal health, which significantly influences the Global Veterinary Animal Vaccines Market Industry. Educational campaigns and outreach programs by veterinary associations have heightened understanding of the benefits of vaccinations. This awareness leads to increased vaccination rates, thereby reducing the prevalence of infectious diseases in animals. As the market continues to expand, the projected compound annual growth rate of 8.48% from 2025 to 2035 indicates that this trend will likely persist, further solidifying the role of vaccines in animal health.

    Market Segment Insights

    Veterinary/Animal Vaccines Type Insights

    <p>The&nbsp;veterinary/animal vaccines&nbsp;market can be grouped into the following sub-segments by type:</p>

    <p>The attenuated vaccines sub-segment held the highest market share last year because they do a better job of boosting animals’ immune systems than other vaccines do. Also, animals who get attenuated vaccines need fewer booster shots less often. Most booster vaccines are given to animals orally.&nbsp;</p>

    <p>This makes them less effective in strengthening the animals’ immune systems and keeping them healthier than vaccines that are given by injection.&nbsp;</p>

    Veterinary/Animal Vaccines Disease Insights

    <p>The&nbsp;Veterinary (Animal) Vaccines Market can be grouped into the following sub-segments by disease:</p>

    Veterinary/Animal Vaccines Technology Insights

    <p>The&nbsp;Veterinary (Animal) Vaccines Market can be grouped into the following sub-segments by type:</p>

    <p>By Type (Livestock)</p>

    <p>The Department of Animal Husbandry and Dairying (DAHD) advised states to immunize cattle and buffaloes with the available Goat pox vaccine on September 20, 2021, despite the fact that lumpy skin disease has already killed almost 1 lakh cattle and infected over 20 lakh animals across 15 states. The only manufacturer of the goatpox vaccine in the nation at the time of authorization was Hester Biosciences in Gujarat; IIL, the Hyderabad-based Brilliant Bio Pharma Pvt Ltd, introduced its goatpox vaccine in December 2021.</p>

    Get more detailed insights about Veterinary (Animal) Vaccines Market Research Report - Forecast till 2032

    Regional Insights

    Key Companies in the Veterinary/Animal Vaccines Market market include

    Industry Developments

    • Many key companies in the Veterinary (Animal) Vaccines Market have stayed successful by entering into strategic partnerships with other successful companies. They have managed to develop a new vaccine for poultry (chicks to be exact). This is very effective so it has great revenue generation potential.
    • Big companies are partnering up to develop new aquaculture vaccines that will do a better job of protecting aquatic life from diseases.
    • Elanco acquired a new animal vaccine company as part of its expansion strategy

     

    Future Outlook

    Veterinary/Animal Vaccines Market Future Outlook

    <p>The Veterinary (Animal) Vaccines Market is projected to grow at an 8.48% CAGR from 2024 to 2032, driven by increasing pet ownership, advancements in vaccine technology, and rising awareness of animal health.</p>

    New opportunities lie in:

    • <p>Develop personalized vaccines targeting specific animal breeds. Leverage digital platforms for vaccine distribution and education. Invest in R&amp;D for innovative adjuvants to enhance vaccine efficacy.</p>

    <p>By 2035, the Veterinary (Animal) Vaccines Market is expected to achieve substantial growth, reflecting evolving industry dynamics.</p>

    Market Segmentation

    Report Scope

    Attribute/MetricDetails
      Market Size 2032  11.8 (USD) Billion
      CAGR  9.2% (2023-2032)
      Base Year2023
      Forecast Period  2023-2032
      Historical Data  2020
      Forecast Units  Value (USD Billion)
      Report Coverage  Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered  Type, Technology, Region
      Geographies Covered  North America, Europe, Asia-Pacific, Rest of the World
      Key Vendors  Zoetis (US), Virbac SA (France), Merck (US), Phibro Animal Health Corporation (US), Boehringer Ingelheim (Germany), Ceva (France), Elanco (US)
      Key Market Opportunities·  High development opportunities in the upcoming years ·  Technological developments
      Key Market Drivers·  The increasing rate of pet adoption ·  Rising expenditure on the pet treatment ·  High consumption of meat

    Market Highlights

    Author

    Kinjoll Dey
    Research Analyst Level I

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM

    FAQs

    Which regions will have the highest CAGR in veterinary/animal vaccines market?

    North America and Asia-Pacific

    What are the recent trends in the veterinary/animal vaccines market?

    More technological advancement is leading to better and more innovative vaccines

    Who are the key competitors in the veterinary/animal vaccines market?

    Zoetis (US), Virbac SA (France), Merck (US), Phibro Animal Health Corporation (US), Boehringer Ingelheim (Germany), Ceva (France), Elanco (US)

    1. List of Tables and Figures

    Veterinary (Animal) Vaccines Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials